BioMark Diagnostics Announces Peer Reviewed Publication on Detection of Cancer
Vancouver, British Columbia – (June 23 , 2020) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF), a developer of proprietary, non-invasive, and accurate cancer diagnostic solutions to assist in detecting, monitoring and assessing treatment for cancer early and cost effectively, announced today a peer reviewed scientific publication to support its innovative cancer […]
BioMark CEO Interview with SNNLive, Sep 2015
Stock News Now Interview In this SNNLive On-Location, our host spoke with Rashid Ahmed, President and CEO of BioMark Diagnostics Inc. (OTCQB: BMKDF) in New York City, NY.
